Teva Pharmaceuticals' stock sinks 6.5% on Q3 results - Drug Discovery and Development
Teva Pharmaceutical Industries Ltd. - Yesterday we shared Teva's Q1 2020 financial results. View the highlights of our contributions to #COVID19 efforts worldwide, focusing on employee safety and ensuring that quality medicines
TEVVF Stock Price and News / Teva Pharmaceutical Industries, 7.00% Mandatory Convertible Preferred Shares - Stock Price Quote and News - Fintel.io
Teva Reports Third Quarter 2020 Financial Results | Business Wire
TEVA Pre Worlds Netherlands – head to head results
Teva shares rise in Tel Aviv as migraine results buoy investors | The Times of Israel
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Industries Limited 2021 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Gets Actavis Boost, Q4 Results Top Estimates
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva Reports First Quarter 2021 Financial Results | Business Wire
Subcutaneous Cinqair results add to Teva's troubles
Teva Pharmaceutical Industries Ltd.'s Q3 Helped by Actavis Generics Deal -- but Not Quite Enough | Fox Business
Teva Reports Second Quarter 2021 Financial Results
![Teva Pharmaceutical Industries Ltd. Fourth Quarter 2019 Results 2020-02-12¢ described in slide 29-30 - [PDF Document]](https://demo.vdocuments.mx/img/378x509/reader022/reader/2020062110/5ec62f46d0820c0307272546/r-1.jpg "Teva Pharmaceutical Industries Ltd. Fourth Quarter 2019 Results 2020-02-12¢ described in slide 29-30 - [PDF Document]")
Teva Pharmaceutical Industries Ltd. Fourth Quarter 2019 Results 2020-02-12¢ described in slide 29-30 - [PDF Document]
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review
Teva announces positive top-line results from AJOVY clinical trials in Japan - Pharmaceutical Business review
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
Teva's shares surge as first quarter results beat expectations | The Times of Israel
The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
Teva Pharmaceuticals in peer group American glamour stocks | Valuespectrum.com
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
